Ligand Pharma's Partner Novan Submits NDA For Berdazimer Gel For Treatment Of Molluscum

Ligand Pharmaceuticals Inc. (LGND) Friday announced that its partner Novan, Inc. (NOVN) has submitted a New Drug Application FDA for berdazimer gel, 10.3% for the topical treatment of molluscum contagiosum.

Berdazimer gel, 10.3% could release nitric oxide and has anti-viral activity. It is poised to be a first-in-class topical treatment for molluscum, an infection caused by a poxvirus. The infection will result in a benign, mild skin disease characterized by lesions that may appear anywhere on the body.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
United Airlines and Archer Aviation Inc. announced plans to launch the first commercial electric air taxi route in Chicago, between O'Hare International Airport or ORD and Vertiport Chicago. As part of their urban air mobility or UAM network buildout, both companies will utilize Archer's electric vertical takeoff and landing or eVTOL aircraft in the new route. Fort Wayne, Indiana-based Perfection Bakeries D/B/A Aunt Millie's is recalling 8 ct. packages of Our Family White Hot Dog Buns citing the possible presence of undeclared sesame, a known allergen, the U.S. Food and Drug Administration said. The product comes in a printed plastic package marked with "Our Family Hot Dog Buns 8 ct." on the top and has a blue twist tie. Parsippany, New Jersey -based Ascend Laboratories LLC. is recalling Dabigatran Etcxilate capsules citing the detection of N-Nitrosodimethylamine or NDMA impurity, a probable human carcinogen, the U.S. Food and Drug Administration said. The product is used as an oral anticoagulant to lower the risk of stroke and blood clots.
Follow RTT